Showing results (11-20 of 20) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Journal of Hazardous Materials|September 30, 2025
Autocatalytic decomplexation of Cu(II)-EDTA by unactivated peroxymonosulfate: The critical role of in situ complexes-assisted Cu(II) catalysisBinbin Shao, Yonglin Ren, Hongliang Cai, et al.Scientific Reports|April 13, 2023
Performance analysis of the BDSBAS-B1C message in trial operation stageJie Xin, Rui Guo, Jinping Chen, et al.Toxicology|April 21, 2009
Assessment of the renal toxicity of novel anti-inflammatory compounds using cynomolgus monkey and human kidney cellsHongliang Cai, Arun K Agrawal, David A Putt, et al.Biochemistry|March 9, 2005
Exocyclic DNA lesions stimulate DNA cleavage mediated by human topoisomerase II alpha in vitro and in cultured cellsRenier Vélez-Cruz, James N Riggins, J Scott Daniels, et al.Current Opinion in Drug Discovery & Development|February 1, 2005
In vitro ADME phenotyping in drug discovery: current challenges and future solutionsJ Andrew Williams, Jonathan Bauman, Hongliang Cai, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 4, 2010
A humanized UGT1 mouse model expressing the UGT1A1*28 allele for assessing drug clearance by UGT1A1-dependent glucuronidationHongliang Cai, Nghia Nguyen, Vincent Peterkin, et al.Cancer Gene Therapy|May 15, 2018
Regulated intratumoral expression of IL-12 using a RheoSwitch Therapeutic System<sup>®</sup> (RTS<sup>®</sup>) gene switch as gene therapy for the treatment of gliomaJohn A Barrett, Hongliang Cai, John Miao, et al.Bioorganic & Medicinal Chemistry Letters|December 8, 2007
Substituted oxazolidinones as novel NPC1L1 ligands for the inhibition of cholesterol absorptionJeffrey A Pfefferkorn, Scott D Larsen, Chad Van Huis, et al.Bioorganic & Medicinal Chemistry Letters|August 18, 2009
5-(2-Pyrimidinyl)-imidazo[1,2-a]pyridines are antibacterial agents targeting the ATPase domains of DNA gyrase and topoisomerase IVJeremy T Starr, Richard J Sciotti, Debra L Hanna, et al.Proceedings of the National Academy of Sciences of the United States of America|August 16, 2013
Stapled α-helical peptide drug development: a potent dual inhibitor of MDM2 and MDMX for p53-dependent cancer therapyYong S Chang, Bradford Graves, Vincent Guerlavais, et al.Pageof 2